| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YRTPH.2008.04.014 |
| P698 | PubMed publication ID | 18565634 |
| P2093 | author name string | Sunil Kapur | |
| Shixia Feng | |||
| Paul Mendes | |||
| Hans Roethig | |||
| Jingzhu Wang | |||
| P2860 | cites work | Comparison of Effect on Tobacco Consumption and Carbon Monoxide Absorption of Changing to High and Low Nicotine Cigarettes | Q55638153 |
| Validation of biomarkers in humans exposed to benzene: urine metabolites | Q57420882 | ||
| Spontaneous cigarette brand switching: consequences for nicotine and carbon monoxide exposure | Q69192446 | ||
| Circadian blood nicotine concentrations during cigarette smoking | Q70509541 | ||
| Smokers' behaviour and exposure according to cigarette yield and smoking experience | Q71592178 | ||
| High-performance liquid chromatographic-tandem mass spectrometric determination of 3-hydroxypropylmercapturic acid in human urine | Q32005188 | ||
| Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers: evidence from a representative population survey | Q32034593 | ||
| Biomarkers of environmental tobacco smoke exposure | Q33648053 | ||
| Smoking behaviour and compensation: a review of the literature | Q33710230 | ||
| Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes. | Q34402884 | ||
| Carcinogen exposure during short-term switching from regular to "light" cigarettes | Q34424605 | ||
| Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer | Q34704529 | ||
| The retention of tobacco smoke constituents in the human respiratory tract | Q37991374 | ||
| Evaluation of urinary 1-hydroxypyrene, S-phenylmercapturic acid, trans,trans-muconic acid, 3-methyladenine, 3-ethyladenine, 8-hydroxy-2'-deoxyguanosine and thioethers as biomarkers of exposure to cigarette smoke | Q39746008 | ||
| Development of a commercial cigarette "market map" comparison methodology for evaluating new or non-conventional cigarettes | Q40228951 | ||
| Biomarkers to assess the utility of potential reduced exposure tobacco products. | Q40295940 | ||
| Cotinine as a biomarker of environmental tobacco smoke exposure | Q41341571 | ||
| Respiratory retention of nicotine and urinary excretion of nicotine and its five major metabolites in adult male smokers | Q42629778 | ||
| A new method for estimating the retention of selected smoke constituents in the respiratory tract of smokers during cigarette smoking | Q44925460 | ||
| Short-term exposure evaluation of adult smokers switching from conventional to first-generation electrically heated cigarettes during controlled smoking | Q45221728 | ||
| 12-week clinical exposure evaluation of a third-generation electrically heated cigarette smoking system (EHCSS) in adult smokers | Q46488986 | ||
| Influence of smoking fewer cigarettes on exposure to tar, nicotine, and carbon monoxide | Q47597049 | ||
| Short-term clinical exposure evaluation of a second-generation electrically heated cigarette smoking system. | Q51759214 | ||
| Analytical cigarette yields as predictors of smoke bioavailability. | Q54650878 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 295-305 | |
| P577 | publication date | 2008-05-11 | |
| P1433 | published in | Regulatory Toxicology and Pharmacology | Q2138805 |
| P1476 | title | A randomized, controlled exposure study in adult smokers of full flavor Marlboro cigarettes switching to Marlboro Lights or Marlboro Ultra Lights cigarettes | |
| P478 | volume | 51 |
| Q41207912 | A longitudinal study of smokers' exposure to cigarette smoke and the effects of spontaneous product switching |
| Q84359019 | A study to evaluate the effect on Mouth Level Exposure and biomarkers of exposure estimates of cigarette smoke exposure following a forced switch to a lower ISO tar yield cigarette |
| Q85179352 | A survey of mouth level exposure to cigarette smoke in the United States |
| Q33559301 | Abuse liability assessment of tobacco products including potential reduced exposure products |
| Q33936367 | Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention |
| Q38774196 | Cigarette Filter Ventilation and its Relationship to Increasing Rates of Lung Adenocarcinoma. |
| Q33562506 | Clinical trials methods for evaluation of potential reduced exposure products |
| Q37246043 | Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers |
| Q43282374 | Estimating tar and nicotine exposure: human smoking versus machine generated smoke yields |
| Q85179349 | Estimation and correlation of cigarette smoke exposure in Canadian smokers as determined by filter analysis and biomarkers of exposure |
| Q24244287 | Interventions to reduce harm from continued tobacco use |
| Q34542475 | Interventions to reduce harm from continued tobacco use. |
| Q87352667 | Intra- and inter-individual variability in urinary nicotine excretion and plasma cotinine in adult cigarette smokers |
| Q39842206 | Limitations in the characterisation of cigarette products using different machine smoking regimes |
| Q33877118 | Menthol's potential effects on nicotine dependence: a tobacco industry perspective |
| Q37461696 | Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies. |
| Q43416801 | Some consequences of using cigarette machine smoking regimes with different intensities on smoke yields and their variability |
| Q36482371 | Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: Part 2. Biomarkers of exposure |
| Q33857125 | Temporal stability of urinary and plasma biomarkers of tobacco smoke exposure among cigarette smokers |
| Q43212819 | The effect of menthol containing cigarettes on adult smokers' exposure to nicotine and carbon monoxide |
| Q45990067 | The relationship between smoking machine derived tar yields and biomarkers of exposure in adult cigarette smokers in the US. |
| Q93228405 | Tobacco harm reduction: Past history, current controversies and a proposed approach for the future |
| Q28392877 | gammaH2AX: A potential DNA damage response biomarker for assessing toxicological risk of tobacco products |
Search more.